Morolimumab Human Monoclonal Antibody
Morolimumabis a research-grade recombinant antibody targeting CD240D. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
CD240D, RHXIII, Blood group Rh (D) polypeptide, Rh polypeptide 2, RhPII, Rhesus D antigen, RHD
UniProt
Q02161
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-nd
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD46 (AHUS2, CD46 antigen complement regulatory protein, Complement membrane cofactor protein, MCP, Measles virus receptor, Membrane cofactor protein, MIC10, TLX, Trophoblast leucocyte common antigen) (PE)
CD46 (AHUS2, CD46 antigen complement regulatory protein, Complement membrane cofactor protein, MCP, Measles virus receptor, Membrane cofactor protein, MIC10, TLX, Trophoblast leucocyte common antigen) (PE)
Lentiviral human F11R shRNA (UAS) - Lentiviral human F11R shRNA (UAS, GFP) (100)
